Details for Patent: 10,028,963
✉ Email this page to a colleague
Which drugs does patent 10,028,963 protect, and when does it expire?
Patent 10,028,963 protects ZERBAXA and is included in one NDA.
This patent has thirteen patent family members in eight countries.
Summary for Patent: 10,028,963
Title: | Methods for treating intrapulmonary infections |
Abstract: | This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane. |
Inventor(s): | Chandorkar; Gurudatt A. (Waltham, MA), Huntington; Jennifer A. (Reading, MA), Parsons; Tara (Hanover, MA), Umeh; Obiamiwe C. (Acton, MA) |
Assignee: | Merck Sharp & Dohme Corp. (Rahway, NJ) |
Application Number: | 15/629,360 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,028,963
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA | ⤷ Try a Trial | ||||
Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,028,963
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2848012 | ⤷ Try a Trial | |||
China | 103945842 | ⤷ Try a Trial | |||
Eurasian Patent Organization | 028342 | ⤷ Try a Trial | |||
Eurasian Patent Organization | 201490590 | ⤷ Try a Trial | |||
European Patent Office | 2753326 | ⤷ Try a Trial | |||
European Patent Office | 2862569 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |